Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?

Authors :: Ibraheem H. Motabi
Imran K Tailor
Mansour Alfayez
Nawal AlShehry
Syed Ziauddin A. Zaidi
Mohammed A. Marei
Syed Y Altaf
Source :: Hematology/Oncology and Stem Cell Therapy
Publication Year :: 2020
Publisher :: King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd., 2020.

Subjects :: Oncology
medicine.medical_specialty
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MEDLINE
Hematology
General Medicine
Letter to Editor
Internal medicine
medicine
business
Lenalidomide
medicine.drug

Tools